Fighting HIV in the Trump Era: U.S. Advocates Speak Out

October 26, 2017


Fighting HIV in the Trump Era: U.S. Advocates Speak Out

In 2016, much of the conversation among U.S. HIV advocates was about building momentum. A National HIV/AIDS Strategy was in place, anti-stigma and anti-discrimination efforts were moving forward, scientific advances supported pre-exposure prophylaxis [PrEP] and treatment as prevention, and clear backing came from the country's highest political office.

Then, a presidential election happened, and the landscape ahead suddenly looked very different for people engaged in the fight against HIV.

At the 2017 U.S. Conference on AIDS in Washington, D.C., in September, we asked HIV community leaders from around the country how their priorities have changed since the election of Donald J. Trump, what they see as the most important challenges to the fight against HIV under a Trump presidency and how they plan to overcome those challenges.

Interviews for this article were conducted by Charles Sanchez, JD Davids and Olivia G. Ford. Transcripts have been lightly edited for clarity.

Related Stories

What's Your Message to the Trump Administration About the Fight Against HIV?
DACA, Immigrant Rights and the 'Larger Compassion' of the HIV Community
How Trump's Proposed U.S. Aid Cuts Will Affect Health Care in Africa

This article was provided by It is a part of the publication The 21st United States Conference on AIDS.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.